July 27, 2026—Siemens Healthineers has launched capillary testing on the Atellica CH, IM, and CI analyzers after receiving the CE mark for 24 capillary blood testing claims. The menu includes assays that comprise the comprehensive metabolic panel, lipid panels, thyroid, vitamin D, and HbA1c.
“Offering a capillary test menu expands the testing that can be done in the core lab to reach more patients and support more testing needs—all with the same systems they already trust,” Sharon Bracken, head of diagnostics, Siemens Healthineers, said in a press release. “Our efforts to expand capillary claims across our assay menu build upon our broader vision to make testing more accessible, efficient, and patient-friendly.”
Siemens offers four assays with capillary claims in the United States: total protein, alanine aminotransferase, aspartate aminotransferase, and triiodothyronine. The company is pursuing additional capillary testing claims with the FDA, subject to regulatory review.